Cullinan Therapeutics, Inc. · NASDAQ:CGEM

Lynx1 Capital Management LP reported a 7.50% stake in Cullinan Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Aug 14, 2025

Lynx1 Capital Management LP reported a 7.50% stake in Cullinan Therapeutics, Inc., 4,400,842 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).

Stake
7.50%
Shares
4,400,842
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP7.50%4,400,842
Weston Nichols7.50%4,400,842

Source

View original at SEC

Related